Teleflex
HealthTrust strikes deals with Teleflex, Ivera Medical
Echo Therapeutics prices offering | Wall Street Beat
Echo Therapeutics (NSDQ:ECTE) priced its public stock offering at 75¢ per share, saying it expects to raise about $10 million in gross proceeds.
The 13.3 million-share offering includes a 45-day over-allotment option for bookrunner Aegis Capital for another 2 million shares.
Novation cuts new deals with medical device giants
Coopersurgical slaps Teleflex Medical with patent lawsuit over facial surgery tech
Teleflex lands FDA win for Arrow UltraQuik needles
Teleflex CEO leaves Rochester Medical board| Personnel Moves
Teleflex affirms 2012 guidance | Wall Street Beat
Teleflex (NYSE:TFX) said yesterday that it expects its 2012 earnings to meet Wall Street’s expectations, but forecast softer profits for the coming year.
The Limerick, Pa.-based medical device company said its "preliminary financial goals" for 2013 are for sales growth of 11%-13% and adjusted EPS of $4.70-$4.90.
Teleflex lands FDA clearance for Nylus vascular access catheter
Limerick, Pa.-based surgical device maker Teleflex’s (NYSE:TFX) Semprus BioSciences subsidiary won FDA 510(k) clearance for its Nylus peripherally inserted central catheter, featuring the proprietary Semprus Sustain platform technology.
Mako Surgical preps $40M public offering | Wall Street Beat
Mako Surgical (NSDQ:MAKO) said it’s planning to sell some 3 million shares of its own stock in an offering worth about $40 million.*
GPOs: Premier signs new contracts with Teleflex
Group purchasing organization Premier signed a pair of 3-year contract agreements with surgical device maker Teleflex (NYSE:TFX) for its product portfolio of endotracheal tubes.
Products included in the GPO agreements, are Teleflex’s Rusch and Sheridan endotracheal tubes brands, including Teleflex ISIS HVT, the 1st convertible endotracheal tube, according to the company’s website.